Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04047290
Title A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Akesobio Australia Pty Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Border Medical Oncology COMPLETED Albury New South Wales Australia Details
Scientia Clinical Research Ltd RECRUITING Randwick New South Wales Australia Details
Blacktown Hospital RECRUITING Sydney New South Wales Australia Details
ICON Cancer Foundation RECRUITING South Brisbane Queensland Australia Details
Adelaide Cancer Centre RECRUITING Kurralta Park South Australia Australia Details
Monash Health RECRUITING Clayton Victoria Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field